Deneka A.; Golemis E.; Boumber Y.; Beck T.
(2019)
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. There are few effective therapies for small cell lung cancer (SCLC), a highly aggressive disease representing 15% of total lung cancers. With median survival <2 ...